Pharmaceuticals News and Research

RSS

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

The international medical humanitarian organization Médecins Sans Frontières fears that a new Presidential Decree will make it much more difficult to obtain affordable essential medicines in Ecuador.

6 Jul 2004

Nanotechnology-based applications are accelerating the development of nanomedicine

With the potential for targeted therapy, and therefore reduced side effects, nanomedicine holds the promise of significantly improving quality of life parameters.

5 Jul 2004

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Chemist Galina Rudenskaya from the Moscow State University and her colleagues from small enterprise TRINITA have made an important discovery in medicine, thanks to funding extended by the RFBR and FASIE.

2 Jul 2004

Medicine storage temperatures are too high

The recommended maximum storage and transit temperatures for most medications is 25°C and are set by the pharmaceutical manufacturers.

2 Jul 2004

Gum disease vaccination aim of world-first research

Vaccinating people against gum disease will be the aim of world-first Melbourne research that today receives a $21.2 million boost from the Federal Government.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

No compulsory genetic testing for newborn babies in Europe

European Research Commissioner Philippe Busquin today rejected stories in several media claiming he had called for genetic testing of all newborn babies in Europe.

2 Jul 2004

U.S. drug prices rise by 3.4 percent during the first quarter of 2004, elderly especially hard hit

A new study released by AARP finds manufacturers' wholesale prices for the 197 brand name prescription drugs most frequently used by older Americans continued an upward climb.

1 Jul 2004

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.

1 Jul 2004

New web site dedicated to improving the accuracy of medical news stories

The Newcastle Institute of Public Health (NIPH) has launched a web site dedicated to improving the accuracy of news stories about new medical treatments in the media.

1 Jul 2004

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.

1 Jul 2004

A Center for Human Genetics/Genomics has been established at the University of California

Established in UCSD Health Sciences, which includes the School of Medicine and School of Pharmacy and Pharmaceutical Sciences, the Center brings together UCSD faculty from multiple campus departments and schools including medicine, pharmacy, biology, biostatistics and mathematics.

30 Jun 2004

Ethical, social and legal aspects of human genetic testing

On 6th and 7th May 2004, the European Commission invited all interested parties to attend a European citizens' and stakeholders' conference, held in Brussels, to discuss the ethical, social and legal aspects of human genetic testing in research and healthcare applications.

30 Jun 2004

Pharmaceuticals News and Research

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

Nanotechnology-based applications are accelerating the development of nanomedicine

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Medicine storage temperatures are too high

Gum disease vaccination aim of world-first research

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

No compulsory genetic testing for newborn babies in Europe

U.S. drug prices rise by 3.4 percent during the first quarter of 2004, elderly especially hard hit

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New web site dedicated to improving the accuracy of medical news stories

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

A Center for Human Genetics/Genomics has been established at the University of California

Ethical, social and legal aspects of human genetic testing

Patent for orally administrable pharmaceutical may aid treatment of overdose patients

U-M scientists say Wnt protein prevents obesity by inhibiting fat cell development

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

UK launch of The Institute of Medical Law

Exelixis files new drug application for a proprietary novel anticancer compound

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

Continued commercial development of research into DNA repair

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News